Comprehensive Canadian Review of the Off-Label Use of Recombinant Activated Factor VII in Cardiac Surgery-Reference-Cited by-同舟云学术

Comprehensive Canadian Review of the Off-Label Use of Recombinant Activated Factor VII in Cardiac Surgery

Published:2008-07-22 Issue:4 Volume:118 Page:331-338
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Karkouti Keyvan¹,Beattie W. Scott¹,Arellano Ramiro¹,Aye Tim¹,Bussieres Jean S.¹,Callum Jeannie L.¹,Cheng Davy¹,Heinrich Lee¹,Kent Blaine¹,Lee Trevor W.R.¹,MacAdams Charles¹,Mazer C. David¹,Muirhead Brian¹,Rochon Antoine G.¹,Rubens Fraser D.¹,Sawchuk Corey¹,Wang Shaohua¹,Waters Terrence¹,Wong Bill I.¹,Yau Terrence M.¹

Affiliation:

1. From the University Health Network, Toronto General Hospital, Department of Anesthesia, Toronto, Ontario, Canada (K.K.). For affiliations of other authors, please see the Disclosures Table.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference36 articles.

1. The independent association of massive blood loss with mortality in cardiac surgery

2. Recombinant Activated Factor VII in Cardiac Surgery: A Systematic Review

3. The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference

4. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Prothrombin Complex Concentrate with Activated Factor VII Use for Bleeding Following Cardiopulmonary Bypass in Children;World Journal for Pediatric and Congenital Heart Surgery;2023-03-15

2. What Drugs Decrease Perioperative Bleeding?;Evidence-Based Practice of Anesthesiology;2023

3. Factor eight inhibitor bypassing activity for refractory bleeding in coronary artery bypass grafting: A propensity‐matched analysis;Research and Practice in Thrombosis and Haemostasis;2022-11

4. Recombinant activated factor VII for hemostasis in patients undergoing complex ascending aortic surgery: A single‐center, single‐surgeon retrospective analysis;Journal of Cardiac Surgery;2021-10-04

5. The Use of Factor Eight Inhibitor Bypass Activity (FEIBA) for the Treatment of Perioperative Hemorrhage in Left Ventricular Assist Device Implantation;Journal of Cardiothoracic and Vascular Anesthesia;2021-09